Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The primary objective of this study is to identify and describe patient behaviors and clinical outcomes among patients who have tested positive for mild to moderate COVID-19.
This virtual observational cohort study will describe patient behaviors and clinical outcomes of subjects who tested positive for COVID-19. Among those with positive tests, predictors of time to recovery, post-COVID function and outcomes will be identified. Individuals who test negative and positive for SARS-CoV-2 will be enrolled in the study.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| SARS-CoV-2 Positive | Other | Participants who have tested positive for SARS-CoV-2, both with and without symptoms | ||
| SARS-CoV-2 Negative | Other | Participants who have tested negative for SARS-CoV-2 |
| Measure | Description | Time Frame |
|---|---|---|
| To identify and describe patient behaviors and clinical outcomes among patients who have tested positive for COVID-19 | Up to 12 months |
| Measure | Description | Time Frame |
|---|---|---|
| To describe recovery in patients with test-confirmed COVID-19 infection including time to recovery and functional improvement | Up to 12 months | |
| To develop prediction tools for time to recovery, function and outcomes in patients with COVID-19 identified by home testing |
Not provided
Inclusion Criteria:
Exclusion Criteria:
- Unable or unwilling to provide informed consent
Not provided
Not provided
Not provided
Individuals who have valid COVID-19 test results.
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Timothy Bauer, PhD | Everly Health | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Everlywell, Inc | Austin | Texas | 78703 | United States |
Not provided
Not provided
Not provided
Not provided
| Up to 12 months |
| To describe users and the utilization of COVID-19 home testing over time by geography, demographics, and comorbidity | Up to 12 months |
| To describe the feasibility of COVID-19 home testing | Up to 12 months |